Ovarian Cancers
-15%
portes grátis
Ovarian Cancers
Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
Lecuru, Fabrice; Pujade-Lauraine, Eric
Springer International Publishing AG
10/2016
286
Dura
Inglês
9783319321080
15 a 20 dias
This book provides an overview of the latestdevelopments in the concepts and management of ovarian cancer.
PART 1: OVARIAN CANCER MANAGEMENTChapter 1. Clinical research in Europe dedicated to ovarian cancersE. Pujade-Lauraine, Paris, France Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe Chapter 7. Onco-fertility applied to ovarian cancers Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere Chapter 9.Elderly C. Falandry, Lyon, France Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse) Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
This book provides an overview of the latestdevelopments in the concepts and management of ovarian cancer.
PART 1: OVARIAN CANCER MANAGEMENTChapter 1. Clinical research in Europe dedicated to ovarian cancersE. Pujade-Lauraine, Paris, France Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe Chapter 7. Onco-fertility applied to ovarian cancers Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere Chapter 9.Elderly C. Falandry, Lyon, France Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse) Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
